The present study demonstrates that melatonin, at 1 mM concentration, reduces the synthesis of oestrogens in C6 glioma cells, through the inhibition of aromatase, the enzyme that catalyses the rate-limiting step in the conversion of androgens into oestrogens (Zhou et al, 1993). Here, CYP19A1 is linked to central nervous system cancer.